Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and glucagon-like peptide 1

cetylpyridinium chloride anhydrous has been researched along with glucagon-like peptide 1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besanko, LK; Burgstad, C; Chapman, MJ; Deane, AM; Fraser, RJ; Holloway, RH; Horowitz, M; Jones, KL; Nguyen, NQ; Rayner, CK; Stevens, JE1
Bound, MJ; Horowitz, M; Jones, KL; Rayner, CK; Standfield, SD; Wu, T1
Christiansen, JS; Dejgaard, A; Frøkiær, J; Holst, JJ; Jonassen, T; Rittig, S; Skov, J1
Aulinger, BA; D'Alessio, DA; Prigeon, RL; Vahl, TP; Wilson-Pérez, HE1
Meier, JJ; Nauck, MA1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and glucagon-like peptide 1

ArticleYear
Incretin hormones: Their role in health and disease.
    Diabetes, obesity & metabolism, 2018, Volume: 20 Suppl 1

    Topics: Diabetes Mellitus, Type 2; Eating; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose; Health; Humans; Incretins; Insulin Secretion; Obesity; Weight Loss

2018

Trials

4 trial(s) available for cetylpyridinium chloride anhydrous and glucagon-like peptide 1

ArticleYear
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:1

    Topics: Adult; Blood Glucose; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Glucagon-Like Peptide 1; Guanosine; Health; Hormone Antagonists; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Peptide Fragments; Placebos

2010
Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:4

    Topics: Adult; Blood Glucose; C-Peptide; Cholagogues and Choleretics; Double-Blind Method; Glucagon; Glucagon-Like Peptide 1; Glucose; Health; Humans; Infusion Pumps; Insulin; Intestine, Small; Male; Taurocholic Acid

2013
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:4

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Glomerular Filtration Rate; Glucagon-Like Peptide 1; Health; Hemodynamics; Humans; Kidney; Male; Placebos; Regional Blood Flow; Renin-Angiotensin System; Urinalysis; Young Adult

2013
β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6

    Topics: Adult; Blood Glucose; Drug Resistance; Female; Glucagon-Like Peptide 1; Glucose Clamp Technique; Health; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Obesity; Thinness; Young Adult

2015